Read Time:6 Second
Emergent BioSolutions stock gains after FDA approves the company’s opioid overdose-reversing nasal spray, Narcan, for over-the-counter sales.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
